comparemela.com

Latest Breaking News On - Scientific company profile - Page 1 : comparemela.com

Insider Buying: XRF Scientific Limited (ASX:XRF) Insider Acquires 19,200 Shares of Stock

XRF Scientific Limited (ASX:XRF – Get Rating) insider David Brown acquired 19,200 shares of the company’s stock in a transaction on Tuesday, May 16th. The shares were acquired at an average price of A$1.13 ($0.76) per share, for a total transaction of A$21,696.00 ($14,561.07). David Brown also recently made the following trade(s): On Tuesday, May […]

David Brown Buys 51,000 Shares of XRF Scientific Limited (ASX:XRF) Stock

XRF Scientific Limited (ASX:XRF – Get Rating) insider David Brown acquired 51,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 9th. The shares were acquired at an average cost of A$1.18 ($0.80) per share, with a total value of A$60,180.00 ($40,938.78). David Brown also recently made the following trade(s): On […]

Comparing SciPlay (NASDAQ:SCPL) and Core Scientific (NASDAQ:CORZ)

SciPlay (NASDAQ:SCPL – Get Rating) and Core Scientific (NASDAQ:CORZ – Get Rating) are both small-cap consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations. Insider and Institutional Ownership 18.6% of SciPlay shares are […]

Core Scientific, Inc (NASDAQ:CORZ) Insider Darin Feinstein Sells 500,000 Shares

Core Scientific, Inc. (NASDAQ:CORZ – Get Rating) insider Darin Feinstein sold 500,000 shares of Core Scientific stock in a transaction on Thursday, June 2nd. The stock was sold at an average price of 3.07, for a total transaction of 1,535,000.00. Following the transaction, the insider now owns 33,393,271 shares in the company, valued at approximately […]

Boston Scientific Co (NYSE:BSX) Expected to Post Quarterly Sales of $3 22 Billion

Wall Street analysts expect that Boston Scientific Co. (NYSE:BSX – Get Rating) will announce $3.22 billion in sales for the current quarter, Zacks Investment Research reports. Nine analysts have issued estimates for Boston Scientific’s earnings, with the lowest sales estimate coming in at $3.20 billion and the highest estimate coming in at $3.24 billion. Boston […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.